» Articles » PMID: 35183657

Designing Electrospun Fiber Platforms for Efficient Delivery of Genetic Material and Genome Editing Tools

Overview
Specialty Pharmacology
Date 2022 Feb 20
PMID 35183657
Authors
Affiliations
Soon will be listed here.
Abstract

Electrospun fibers are versatile biomaterial platforms with great potential to support regeneration. Electrospun fiber characteristics such as fiber diameter, degree of alignment, rate of degradation, and surface chemistry enable the creation of unique, tunable scaffolds for various drug or gene delivery applications. The delivery of genetic material and genome editing tools via viral and non-viral vectors are approaches to control cellular protein production. However, immunogenicity, off-target effects, and low delivery efficiencies slow the progression of gene delivery strategies to clinical settings. The delivery of genetic material from electrospun fibers overcomes such limitations by allowing for localized, tunable delivery of genetic material. However, the process of electrospinning is harsh, and care must be taken to retain genetic material bioactivity. This review presents an up-to-date summary of strategies to incorporate genetic material onto or within electrospun fiber platforms to improve delivery efficiency and enhance the regenerative potential of electrospun fibers for various tissue engineering applications.

Citing Articles

Hybrid fibrous architectures-mediated gene transfer by pDNA nanoparticles into macrophages.

Ghitman J, Gradisteanu Pircalabioru G, Deleanu C, Vasile E, Iliescu C, Iovu H Heliyon. 2024; 10(19):e38071.

PMID: 39398054 PMC: 11471199. DOI: 10.1016/j.heliyon.2024.e38071.


Transduction and Genome Editing of the Heart with Adeno-Associated Viral Vectors Loaded onto Electrospun Polydioxanone Nonwoven Fabrics.

Furuno K, Suzuki K, Sakai S Biomolecules. 2024; 14(4).

PMID: 38672522 PMC: 11047894. DOI: 10.3390/biom14040506.


Unidirectional gene delivery electrospun fibrous membrane via charge repulsion for tendon repair.

Liu J, Chen L, Sun Z, Tao Z, Pavel V, Li Y Bioact Mater. 2024; 37:191-205.

PMID: 38549775 PMC: 10972767. DOI: 10.1016/j.bioactmat.2024.03.008.


Electrospun Nanofibers Encapsulated with Natural Products: A Novel Strategy to Counteract Skin Aging.

Serra D, Garroni G, Cruciani S, Coradduzza D, Pashchenko A, Amler E Int J Mol Sci. 2024; 25(3).

PMID: 38339184 PMC: 10856659. DOI: 10.3390/ijms25031908.


Unleashing the healing potential: Exploring next-generation regenerative protein nanoscaffolds for burn wound recovery.

Si L, Guo X, Bera H, Chen Y, Xiu F, Liu P Asian J Pharm Sci. 2024; 18(6):100856.

PMID: 38204470 PMC: 10777420. DOI: 10.1016/j.ajps.2023.100856.


References
1.
Maddaluno L, Urwyler C, Werner S . Fibroblast growth factors: key players in regeneration and tissue repair. Development. 2017; 144(22):4047-4060. DOI: 10.1242/dev.152587. View

2.
Chou S, Carson D, Woodrow K . Current strategies for sustaining drug release from electrospun nanofibers. J Control Release. 2015; 220(Pt B):584-91. PMC: 5235363. DOI: 10.1016/j.jconrel.2015.09.008. View

3.
Del Pozo-Acebo L, Lopez de Las Hazas M, Tome-Carneiro J, Gil-Cabrerizo P, San-Cristobal R, Busto R . Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy. Int J Mol Sci. 2021; 22(3). PMC: 7865385. DOI: 10.3390/ijms22031105. View

4.
Jimenez P, Rampy M . Keratinocyte growth factor-2 accelerates wound healing in incisional wounds. J Surg Res. 1999; 81(2):238-42. DOI: 10.1006/jsre.1998.5501. View

5.
Green E, Lee R . Proteins and small molecules for cellular regenerative medicine. Physiol Rev. 2013; 93(1):311-25. PMC: 3781772. DOI: 10.1152/physrev.00005.2012. View